Cenobamate: real-world data from a retrospective multicenter study.

Stephan LauxmannDavid HeuerJan HeckelmannFlorian P FischerMelanie SchreiberElisabeth SchriewerGuido WidmanYvonne WeberHolger LercheMichael AlberSigrid Schuh-HoferStefan Wolking

Published in: Journal of neurology (2024)

CNB proved to be a highly effective and generally well-tolerated ASM in patients with severe drug-resistant epilepsy, comprising a broad array of epilepsy syndromes beyond focal epilepsy.

Keyphrases

drug resistant
multidrug resistant
acinetobacter baumannii
electronic health record
high throughput
mass spectrometry
machine learning
data analysis
drug induced